SynMed

SynMed SynMed (previously trading as Synectics Medical) is one of the UK’s leading suppliers of diagnostic and therapeutic equipment in gastroenterology

SynMed
SynMed House
Unit 7, The Pavillions
6 Kinetic Crescent
Innova Park
ENFIELD
EN3 7FJ

Day 3 of BSG Live’25 at SEC Glasgow, visit us on the SYNMED stand   to see latest developments in Motility and pH monito...
25/06/2025

Day 3 of BSG Live’25 at SEC Glasgow, visit us on the SYNMED stand to see latest developments in Motility and pH monitoring options, including;

• alpHaONE System wireless pH monitoring.
• alpHaFLEX catheter based pH/Impedance Monitoring System.
• MANOalpHa High Resolution Manometry System.
• Details on upcoming Impedance/pH Reflux Testing & HRM Clinical Training Seminar, September 3rd 2025

If you can’t make it to the SYNMED stand but would like to hear more, simply contact sales@synmed.co.uk

We are at BSG Live’25, SEC Glasgow! visit us on stand C4 for ‘hands on’ training opportunities with the improved Ovesco ...
24/06/2025

We are at BSG Live’25, SEC Glasgow! visit us on stand C4 for ‘hands on’ training opportunities with the improved Ovesco OTSC® system- OTSC®neo, no need to pre book, just find our Ovesco booth and one of the team will welcome you.
Learn more about;
ArgoCap for the precise ablation of superficial lesions during APC treatment in the GI tract
BougieCap for the dilation of stenosis and strictures in the upper gastrointestinal tract
Hemopill a non-imaging, swallowable sensor capsule for the real-time detection of acute bleeding in the oesophagus, stomach, and small intestine.
Latest UK training options for the Ovesco Full Thickness Resection Device (FTRD).

If you're not attending BSG, remember we can always offer ‘hands on’ OTSC®neo training sessions onsite at your hospital, contact Sales@Synmed.co.uk

FTRD® shows low recurrence rates and high success in treating difficult colorectal lesions Key findings• Colorectal FTRD...
29/05/2025

FTRD® shows low recurrence rates and high success in treating difficult colorectal lesions

Key findings
• Colorectal FTRD® demonstrates a low overall recurrence rate of 9.9% (n=9/91)
• Majority (66.6%) of recurrent or residual lesions (RRLs) were successfully treated endoscopically. All of them occurred in non-lifting adenoma.
• No late adverse events reported
• Close follow-up is crucial for optimal outcomes, especially in non-lifting adenomas and early carcinomas

Study details
• Retrospective analysis conducted at University Medical Center Freiburg from 2014 to 2021
• Included 91 patients with at least one endoscopic follow-up examination
• Indications for FTRD®: Non-lifting adenoma (n=65), subepithelial tumors (n=18), early carcinoma (n=8)
• Median follow-up period was 17 months (range 2-86)

Mueller J, Miedtke V, Kuellmer A, Schiemer M, Bettinger D, Thimme R, Schmidt A. Outcome after colorectal full-thickness resection and management of recurrence. Endosc Int Open. 2024;12(8):E989-E995. DOI: 10.1055/a-2375-7568.

Email Sales@Synmed.co.uk for more information on training opportunities for FTRD

#

New case study on the OTSG Xcavator® by Karna et al. demonstrates OTSG Xcavator® effective for removal of large necrotic...
21/05/2025

New case study on the OTSG Xcavator® by Karna et al. demonstrates OTSG Xcavator® effective for removal of large necrotic debris in direct endoscopic necrosectomy (DEN)*

Key findings

OTSG® Xcavator could remove large pieces of necrosum of between 10-15cm in length
Complete resolution of necrosis was achieved in two sessions
No adverse events occurred

Case details

63-year-old man with history of semaglutide-induced necrotizing pancreatitis leading to an infected walled-off necrotic collection
DEN with traditional tools such as forceps, snares and suction were challenging due to the nature of the large, thick and pasty necrotic tissue adherent to the cyst wall
After the procedure, LAMS were removed and replaced with plastic double-pigtail stents across the cystogastrostomy

Karna R, Arayakarnkul S, Wilson N, Bilal M. Successful necrosectomy using the over-the-scope grasping device: a tool for solid necrotic debris. Endoscopy. 2024;56(3):E957-E958. Doi: 10.1055/a-2443-4173

Email Sales@Synmed.co.uk for more details or to arrange a demonstration.

Discover the potential of the HemoPill® acute as a triage tool!A UK study by D'Cunha Kamath et al. explores how the Hemo...
29/04/2025

Discover the potential of the HemoPill® acute as a triage tool!

A UK study by D'Cunha Kamath et al. explores how the HemoPill® acute was used to reduce inpatient gastroscopies.

UK study on the HemoPill® acute shows that the bleeding-detection capsule could reduce the need for inpatient gastroscopies in patients with suspected non-variceal acute upper gastrointestinal bleeding (AUGIB)

Key findings
• 10 patients were given the HemoPill® acute. The HemoPill® acute showed a negative result in 6 and a positive result in 4 patients
• Adverse events occcurred in 0 cases and 90-day mortality was 0%
• HemoPill® as a triage tool led to a reduction of inpatient gastroscopies
• Patient with suspected non-variceal AUGIB and negative HemoPill® results could be safely managed as outpatients

Study details
• All patients included had been admitted to hospital with a suspected UGI bleed. The median Glasgow Blatchford Score was 9 and the median Rockall Score 4
• No pre-procedure fasting was required
• All patients with negative capsule results were managed as outpatients and underwent urgent outpatient gastroscopy
• All patients with positive capsule results were managed as inpatients and underwent inpatient gastroscopy

D'Cunha Kamath A, Friel JH, Braddy-Green C. Novel method for risk stratifying suspected acute non-variceal upper GI bleeds using a blood-detection capsule: first UK hospital experience. Frontline Gastroenterol. 2025; flgastro-2024-102883. Doi: 10.1136/flgastro-2024-102883.
Read more; https://fg.bmj.com/content/early/2025/02/08/flgastro-2024-102883

Email Sales@Synmed.co.uk for more information

FTRD® enabled R0 resection without complications of an isolated follicular lymphoma in the cecum Key findings• Isolated ...
18/02/2025

FTRD® enabled R0 resection without complications of an isolated follicular lymphoma in the cecum

Key findings
• Isolated GI follicular lymphoma (GI-FL) in the cecum was referred for endoscopic treatment
• With FTRD®, R0 resection without complications was achieved. Final pathology revealed a 23x21x8mm grade 1-2 follicular lymphoma with negative margins
• Patient is clinically well in the six-month follow-up
• Authors conclude that FTRD® appears effective for small isolated colonic GI-FL

Case details
• 62-year-old woman with a sessile polyp (12mm submucosal lesion) in the cecum
• PET-CT without evidence of malignancy, bone marrow biopsy was normal without evidence of lymphoma, suggesting an isolated GI-FL
• 1-year follow-up is pending

Mauro AJ, Bell PD, McGrath K. Gastrointestinal Follicular Lymphoma of the Cecum Treated via Endoscopic Full-Thickness Resection. ACG Case Rep J. 2024;11(8):e01466. DOI: 10.14309/crj.0000000000001466 For further clinical and product information, please follow our website links on the FTRD® System.

👉 Learn more about FTRD® and its benefits: https://lnkd.in/dnBWDUM
👉 Email Sales@Synmed.co.uk for details of UK training opportunities

FTRD® - a diagnostic and therapeutic option for T1 carcinomaFTRD® is a minimally invasive alternative to surgical resect...
13/02/2025

FTRD® - a diagnostic and therapeutic option for T1 carcinoma

FTRD® is a minimally invasive alternative to surgical resection for T1 carcinomas. Through its high R0 resection rate, it offers high-quality pathological specimens for exact histologic risk stratification and can serve as a potentially curative treatment.

👉 Learn more about FTRD® and its benefits: https://synecticsmedical.co.uk/product-category/endoscopic-full-thickness-resection/
👉 Email Sales@Synmed.co.uk for details of UK training opportunities

05/02/2025

Find out more about the HemoPill® acute! 💊

Developed to help exclude or confirm bleeding in the oesophagus, stomach and small intestine, this telemetric capsule is easy to use for both patients and physician. It requires no preparation of the patient, is smaller than regular video capsules and the data is immediately available without the need for time-consuming evaluation. That way, physicians can quickly determine whether a patient has an acute GI bleeding and needs an urgent endoscopy – or whether there is no acute bleeding present and an endoscopy can instead be scheduled during regular working hours.

👉 Contact Sales@Synmed.co.uk for more information or to arrange a period of evaluation

If you missed registering for webinar ‘A Decade of FTRD® - Global Insights and Future Directions’ 👉 Find a recording and...
10/12/2024

If you missed registering for webinar ‘A Decade of FTRD® - Global Insights and Future Directions’ 👉 Find a recording and more information on the webinar here: https://lnkd.in/dSkt3vSE

See and listen to a range of experienced clinicians sharing their insights: Prof. Dr. med. Karel C**a from RKH Klinikum in Ludwigsburg, Dr. Gregory B. Haber from NYU Langone Medical Center, Dr. Barbara A. J. Bastiaansen from Amsterdam University Medical Centers, Dr. Philipp S. Ge from the University of Texas and Dr. Zaheer Nabi from the Asian Institute of Gastroenterology.

Email Sales@Synmed.co.uk for more information and training opportunities

The next UK FTRD® training day is confirmed for Monday January 20th 2025 at Liverpool John Moore’s University. The key o...
24/10/2024

The next UK FTRD® training day is confirmed for Monday January 20th 2025 at Liverpool John Moore’s University. The key objective of this one day course is to enable centres to offer endoscopic Full Thickness Resection (eFTR) procedures, formerly only carried out by surgery. In addition, all attendees will receive the training certificate required before using the FTRD® System.

To register your interest email Sales@Synmed.co.uk

BougieCap shows promising results in EoE Stricture DilationBougieCap enables dilation under visual control in case of eo...
10/10/2024

BougieCap shows promising results in EoE Stricture Dilation

BougieCap enables dilation under visual control in case of eosinophilic oesophagitis stricture

Key findings
• BougieCap enabled dilation under direct visualisation
• Dilation was performed with no resistance at 12mm, mild resistance at 14mm and significant resistance at 16mm
• Two jagged, deep mucosal tears without evidence of perforation were observed
• Repeat dilation was performed 2 weeks later with 16mm BougieCap, followed by 17mm- and 18mm wire-guided Savary dilators, leading to a resolution of the luminal narrowing

Case details
• A 44-year-old-man with eosinophilic oesophagitis presented with chronic dysphagia
• He had previously undergone multiple dilations, the last in 2019 with a balloon dilation of up to 10mm
• Upper endoscopy 6 month’s prior revealed eosinophilic oesophagitis with significant narrowing 6cm in length

Chen B, Diehl DL. Functional luminal imaging probe assessment of eosinophilic esophagitis stricture followed by optical-haptic dilation with a dilating cap. VideoGIE. 2024;9(5):224–5.

Contact Sales@synmed.co.uk for more Product information and details of onsite training options.

The ArgoCap™ is the latest Ovesco product in the ScopeCaps family. As an endoscopic cap for safe and precise APC treatme...
01/10/2024

The ArgoCap™ is the latest Ovesco product in the ScopeCaps family.

As an endoscopic cap for safe and precise APC treatment, it enables homogeneous and focused treatment thanks to the fixed positioning of the APC probe.

Optimise your endoscopic toolbox!

Email sales@synmed.co.uk for more information and details of the onsite training we can offer.

Click here to find more information on the ArgoCap™ and other ScopeCaps products: https://ow.ly/v6V850Sf3SS

Address

Enfield
EN37FJ

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm

Telephone

+441992780570

Alerts

Be the first to know and let us send you an email when SynMed posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to SynMed:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram